Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob J Bosman

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Critical Care (London, England)|May 24, 2019
Clinically relevant pharmacokinetic knowledge on antibiotic dosing among intensive care professionals is insufficient: a cross-sectional studyLucas M Fleuren, Luca F Roggeveen, Tingjie Guo, et al.
European Journal of Anaesthesiology|July 18, 2014
Testing a conceptual model on early opening of the microcirculation in severe sepsis and septic shock: a randomised controlled pilot studyPeter H J van der Voort, Mark van Zanten, Rob J Bosman, et al.
Critical Care Medicine|December 31, 2008
Citrate anticoagulation for continuous venovenous hemofiltrationHeleen M Oudemans-van Straaten, Rob J Bosman, Matty Koopmans, et al.
Intensive Care Medicine|June 16, 2010
Hospital mortality is associated with ICU admission timeHans A J M Kuijsten, Sylvia Brinkman, Iwan A Meynaar, et al.
Antimicrobial Agents and Chemotherapy|March 6, 2019
External Evaluation of Population Pharmacokinetic Models of Vancomycin in Large Cohorts of Intensive Care Unit PatientsTingjie Guo, Reinier M van Hest, Luca F Roggeveen, et al.
British Journal of Clinical Pharmacology|July 28, 2020
Why we should sample sparsely and aim for a higher target: Lessons from model-based therapeutic drug monitoring of vancomycin in intensive care patientsTingjie Guo, Reinier M van Hest, Lucas M Fleuren, et al.
Trials|December 20, 2019
Right Dose Right Now: bedside data-driven personalized antibiotic dosing in severe sepsis and septic shock - rationale and design of a multicenter randomized controlled superiority trialLuca F Roggeveen, Lucas M Fleuren, Tingjie Guo, et al.
Pharmaceutical Research|August 25, 2020
Optimizing Predictive Performance of Bayesian Forecasting for Vancomycin Concentration in Intensive Care PatientsTingjie Guo, Reinier M van Hest, Laura B Zwep, et al.
Critical Care (London, England)|September 5, 2022
Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock-a two-centre randomised clinical trialLuca F Roggeveen, Tingjie Guo, Lucas M Fleuren, et al.
Trials|August 19, 2021
Early high-dose vitamin C in post-cardiac arrest syndrome (VITaCCA): study protocol for a randomized, double-blind, multi-center, placebo-controlled trialSander Rozemeijer, Harm-Jan de Grooth, Paul W G Elbers, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Critical Care (London, England)|May 24, 2019
Clinically relevant pharmacokinetic knowledge on antibiotic dosing among intensive care professionals is insufficient: a cross-sectional studyLucas M Fleuren, Luca F Roggeveen, Tingjie Guo, et al.
European Journal of Anaesthesiology|July 18, 2014
Testing a conceptual model on early opening of the microcirculation in severe sepsis and septic shock: a randomised controlled pilot studyPeter H J van der Voort, Mark van Zanten, Rob J Bosman, et al.
Critical Care Medicine|December 31, 2008
Citrate anticoagulation for continuous venovenous hemofiltrationHeleen M Oudemans-van Straaten, Rob J Bosman, Matty Koopmans, et al.
Intensive Care Medicine|June 16, 2010
Hospital mortality is associated with ICU admission timeHans A J M Kuijsten, Sylvia Brinkman, Iwan A Meynaar, et al.
Antimicrobial Agents and Chemotherapy|March 6, 2019
External Evaluation of Population Pharmacokinetic Models of Vancomycin in Large Cohorts of Intensive Care Unit PatientsTingjie Guo, Reinier M van Hest, Luca F Roggeveen, et al.
British Journal of Clinical Pharmacology|July 28, 2020
Why we should sample sparsely and aim for a higher target: Lessons from model-based therapeutic drug monitoring of vancomycin in intensive care patientsTingjie Guo, Reinier M van Hest, Lucas M Fleuren, et al.
Trials|December 20, 2019
Right Dose Right Now: bedside data-driven personalized antibiotic dosing in severe sepsis and septic shock - rationale and design of a multicenter randomized controlled superiority trialLuca F Roggeveen, Lucas M Fleuren, Tingjie Guo, et al.
Pharmaceutical Research|August 25, 2020
Optimizing Predictive Performance of Bayesian Forecasting for Vancomycin Concentration in Intensive Care PatientsTingjie Guo, Reinier M van Hest, Laura B Zwep, et al.
Critical Care (London, England)|September 5, 2022
Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock-a two-centre randomised clinical trialLuca F Roggeveen, Tingjie Guo, Lucas M Fleuren, et al.
Trials|August 19, 2021
Early high-dose vitamin C in post-cardiac arrest syndrome (VITaCCA): study protocol for a randomized, double-blind, multi-center, placebo-controlled trialSander Rozemeijer, Harm-Jan de Grooth, Paul W G Elbers, et al.
Pageof 5